2022 HIV Treatment and Prevention Agents Pharmaceutical Companies 
pharmaphorum
JUNE 29, 2022
COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face.
ISPE
JULY 6, 2023
billion US in 2022 for the global market share for prescription drugs produced using CM. 1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. This is demonstrated by the rise from $1.05 billion US in 2021 to $1.9
Expert insights. Personalized for you.
59 
Let's personalize your content